| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |